Dean Lim
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Geriatrics and Gerontology top 5%
Papers in
- Oncology 39
- Colorectal Cancer Treatments and Studies 17
- Cancer Treatment and Pharmacology 14
- Cancer Immunotherapy and Biomarkers 10
-
- Lung Cancer Treatments and Mutations 11
- Co-authors
- Robert J. Morgan (20 shared papers)Marwan Fakih (25 shared papers)Yun Yen (16 shared papers)Joseph Chao (22 shared papers)Jaideep Sandhu (5 shared papers)Paul Frankel (29 shared papers)Lucille Leong (17 shared papers)Mark E. Davis (3 shared papers)
- Journals
- Journal of Clinical Oncology (24 papers)Cancer Chemotherapy and Pharmacology (7 papers)Annals of Oncology (5 papers)Journal of the National Comprehensive Cancer Network (3 papers)Cancer (2 papers)
- Partner nations
- United StatesTaiwanSingapore
In The Last Decade
Dean Lim
69 papers receiving 2.1k citations
Dean Lim's Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 971
- Geriatrics and Gerontology 109
- Otorhinolaryngology 101
- Cancer Research 330
- Pathology and Forensic Medicine 286
Countries citing papers authored by Dean Lim
This map shows the geographic impact of Dean Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean Lim more than expected).
Fields of papers citing papers by Dean Lim
This network shows the impact of papers produced by Dean Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean Lim. The network helps show where Dean Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside Dean Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer Hit paper breakdown → | 2019 | 441 |
| 2 | 2014 | 296 | |
| 3 | 2008 | 197 | |
| 4 | 2009 | 83 | |
| 5 | 2015 | 73 | |
| 6 | 2016 | 65 | |
| 7 | 2005 | 65 | |
| 8 | Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics. | 2003 | 61 |
| 9 | 2023 | 60 | |
| 10 | 2007 | 56 | |
| 11 | 2018 | 52 | |
| 12 | Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial. | 2009 | 44 |
| 13 | 2004 | 41 | |
| 14 | 2013 | 41 | |
| 15 | 2011 | 36 | |
| 16 | 2014 | 35 | |
| 17 | 2005 | 34 | |
| 18 | 2012 | 34 | |
| 19 | 2008 | 32 | |
| 20 | 2011 | 30 |
About Dean Lim
Dean Lim is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Cancer Research, having authored 72 papers that have together received 2.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (17 papers), Cancer Treatment and Pharmacology (14 papers), Lung Cancer Treatments and Mutations (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), Cancer Genomics and Diagnostics (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Histone Deacetylase Inhibitors Research (6 papers) and Intraperitoneal and Appendiceal Malignancies (6 papers). The work is most often cited by research in Oncology (971 citations), Geriatrics and Gerontology (109 citations), Otorhinolaryngology (101 citations), Cancer Research (330 citations) and Pathology and Forensic Medicine (286 citations). Dean Lim has collaborated with scholars based in United States, Taiwan and Singapore. Frequent co-authors include Robert J. Morgan, Marwan Fakih, Yun Yen, Joseph Chao, Jaideep Sandhu, Paul Frankel, Lucille Leong, Mark E. Davis, Jeremy D. Heidel and Jonathan E. Zuckerman. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Annals of Oncology, Journal of the National Comprehensive Cancer Network and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.